Doxorubicin

"Doxorubicin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.

Descriptor ID	D004317
MeSH Number(s)	D02.455.426.559.847.562.050.200.175 D04.615.562.050.200.175 D09.408.051.059.200.175
Concept/Terms	Doxorubicin Doxorubicin Farmiblastina Farmiblastina Ribodoxo Ribodoxo Rubex Rubex Adriamycin Adriamycin Adriblastin Adriblastin Adriblastine Adriblastina Adriablastine Adriablastin Adrimedac Adrimedac DOXO-cell DOXO-cell DOXO cell Urokit Doxo-cell Urokit Doxo cell Doxolem Doxolem Doxorubicin Hexal Doxorubicin Hexal Doxorubicin Hydrochloride Doxorubicin Hydrochloride Hydrochloride, Doxorubicin Doxorubicin NC Doxorubicin NC Doxorubicina Ferrer Farm Doxorubicina Ferrer Farm Doxorubicina Funk Doxorubicina Funk Doxorubicina Tedec Doxorubicina Tedec Doxorubicine Baxter Doxorubicine Baxter Doxotec Doxotec Myocet Myocet Onkodox Onkodox

Below are MeSH descriptors whose meaning is more general than "Doxorubicin".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Hydrocarbons [D02.455]
Hydrocarbons, Cyclic [D02.455.426]
Hydrocarbons, Aromatic [D02.455.426.559]
Polycyclic Aromatic Hydrocarbons [D02.455.426.559.847]
Naphthacenes [D02.455.426.559.847.562]
Anthracyclines [D02.455.426.559.847.562.050]
Daunorubicin [D02.455.426.559.847.562.050.200]
Doxorubicin [D02.455.426.559.847.562.050.200.175]
Polycyclic Compounds [D04]
Polycyclic Aromatic Hydrocarbons [D04.615]
Naphthacenes [D04.615.562]
Anthracyclines [D04.615.562.050]
Daunorubicin [D04.615.562.050.200]
Doxorubicin [D04.615.562.050.200.175]
Carbohydrates [D09]
Glycosides [D09.408]
Aminoglycosides [D09.408.051]
Anthracyclines [D09.408.051.059]
Daunorubicin [D09.408.051.059.200]
Doxorubicin [D09.408.051.059.200.175]

Below are MeSH descriptors whose meaning is related to "Doxorubicin".

Below are MeSH descriptors whose meaning is more specific than "Doxorubicin".

Doxorubicin
Epirubicin

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Doxorubicin" by people in this website by year, and whether "Doxorubicin" was a major or minor topic of these publications.

Bar chart showing 73 publications over 22 distinct years, with a maximum of 9 publications in 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	1	1
1995	0	1	1
1998	0	1	1
2003	1	1	2
2004	1	2	3
2005	2	0	2
2006	3	3	6
2007	2	4	6
2008	0	1	1
2009	0	3	3
2010	6	3	9
2011	1	1	2
2012	2	2	4
2013	3	1	4
2014	0	4	4
2015	2	2	4
2016	2	0	2
2017	0	4	4
2018	3	1	4
2019	1	2	3
2020	1	2	3
2022	0	4	4

Below are the most recent publications written about "Doxorubicin" by people in Profiles.

Cobb MS, Tao S, Shortt K, Girgis M, Hauptman J, Schriewer J, Chin Z, Dorfman E, Campbell K, Heruth DP, Shohet RV, Dawn B, Konorev EA. Smad3 promotes adverse cardiovascular remodeling and dysfunction in doxorubicin-treated hearts. Am J Physiol Heart Circ Physiol. 2022 12 01; 323(6):H1091-H1107.

View in: PubMed
Sarkar M, Wang Y, Ekpenyong O, Liang D, Xie H. Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 03; 15(2):e1846.

View in: PubMed
Afrin H, Huda MN, Islam T, Oropeza BP, Alvidrez E, Abir MI, Boland T, Turbay D, Nurunnabi M. Detection of Anticancer Drug-Induced Cardiotoxicity Using VCAM1-Targeted Nanoprobes. ACS Appl Mater Interfaces. 2022 Aug 24; 14(33):37566-37576.

View in: PubMed
Sun Y, Davis EW. Multi-Stimuli-Responsive Janus Hollow Polydopamine Nanotubes. Langmuir. 2022 08 16; 38(32):9777-9789.

View in: PubMed
Shrestha B, Wang L, Zhang H, Hung CY, Tang L. Gold Nanoparticles Mediated Drug-Gene Combinational Therapy for Breast Cancer Treatment. Int J Nanomedicine. 2020; 15:8109-8119.

View in: PubMed
Chowdhury N, Chaudhry S, Hall N, Olverson G, Zhang QJ, Mandal T, Dash S, Kundu A. Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment. AAPS PharmSciTech. 2020 Jul 21; 21(6):202.

View in: PubMed
Feng Y, Zhong X, Tang TT, Wang C, Wang LT, Li ZL, Ni HF, Wang B, Wu M, Liu D, Liu H, Tang RN, Liu BC, Lv LL. Rab27a dependent exosome releasing participated in albumin handling as a coordinated approach to lysosome in kidney disease. Cell Death Dis. 2020 07 08; 11(7):513.

View in: PubMed
Alyami M, Bonnot PE, Mercier F, Laplace N, Villeneuve L, Passot G, Bakrin N, Kepenekian V, Glehen O. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. Eur J Surg Oncol. 2021 01; 47(1):123-127.

View in: PubMed
Piccolo V, Corneli P, Zalaudek I, Argenziano G, Conforti C, Alfano R, Russo T. Mees' lines because of chemotherapy for Hodgkin's lymphoma. Int J Dermatol. 2020 Feb; 59(2):e38.

View in: PubMed
Molehin OR, Adeyanju AA, Adefegha SA, Oyeyemi AO, Idowu KA. Protective mechanisms of protocatechuic acid against doxorubicin-induced nephrotoxicity in rat model. J Basic Clin Physiol Pharmacol. 2019 Jul 08; 30(4).

View in: PubMed

People

Explore

Similar Concepts

Top Journals